Skip to content
Stop using now Drug recall · FDA · Published March 6, 2025

QuVa Pharma Fentanyl Citrate Injection Recall: Lack of Sterility Assurance

QuVa Pharma recalls specific fentanyl injections due to lack of sterility assurance. Affected lots expire April 2025. Consumers should not use these products.

🇺🇸 FDA recall #D-0296-2025DrugQuVa Pharma ›
Take action

Contact the company

Recalling firmQuVa Pharma, Inc.1075 W Park One Dr Ste 100 · Sugar Land, TX 77478-2576
✎ GovInfoNow plain-language explainer

What happened, in plain English

QuVa Pharma is recalling certain fentanyl injections that may not be sterile. This could lead to infections if used improperly. The recall affects specific lots with expiration dates up to April 2025. Read more at govinfonow.com/recall/32240-quva-pharma-fentanyl-citrate-injection-recall-lack-of-sterility-assurance.

Source Summary by GovInfoNow · govinfonow.com/recall/32240-quva-pharma-fentanyl-citrate-injection-recall-lack-of-sterility-assurance · Updated August 17, 2026 · FDA enforcement record: FDA #D-0296-2025

Cite this page

“QuVa Pharma Fentanyl Citrate Injection Recall: Lack of Sterility Assurance.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32240-quva-pharma-fentanyl-citrate-injection-recall-lack-of-sterility-assurance. Based on FDA recall #D-0296-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0296-2025%22&limit=1).

Why it’s dangerous

The injections lack assurance of sterility, meaning they could contain harmful bacteria or other contaminants. If used, this could cause serious infections or other health complications.

Who’s affected

Healthcare professionals using these injections for epidural procedures are affected. Patients receiving these injections at medical facilities using the recalled lots are at risk.

How to tell if you have this one

Check the product label for the specific lot numbers: 10140284, 10140285, 10140315, 10140316, 10140510, 10140916. The expiration dates range from April 2025 to April 2025.

  • Brand
    QuVa Pharma
  • Category
    Drug
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    U.S. Nationwide
Recall numberProduct, codes & lotsQuantity
D-0295-2025fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.1% Bupivacaine HCl 100 mg/100 mL (1 mg/mL), 100 ml in NS Yellow CADD FSFF, Injection for Epidural Use (Not intended For IV Use), Compounded, For Institutional or Office Use Only, QuVa Pharma, 1075 West Park One Drive, Suite 100, Sugar Land, Tx 77478. NDC: 70092-1255-75; Lots: 10140259, 10140539, 10140687, 10140688; Exp 04/24/2025N/A
D-0296-2025fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.125% Bupivacaine HCl 125 mg/100 mL (1.25 mg/mL), 100 ml in NS Yellow CADD FSFF, Injection for Epidural Use (Not intended For IV Use), Compounded, For Institutional or Office Use Only, QuVa Pharma, 1075 West Park One Drive, Suite 100, Sugar Land, Tx 77478. NDC: 70092-1255-75; Lot, expiry: Lots 10140284, 10140285, 10140315, 10140316, exp 04/08/2025; Lot 10140510, exp 04/14/2025; Lot 10140916, exp 04/24/20252,310 cassettes
D-0297-2025fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.2% ROPivacaine HCl 200 mg/100 mL (2 mg/mL), 100 ml in NS Yellow CADD FSFF, Injection for Epidural Use (Not intended For IV Use), Compounded, For Institutional or Office Use Only, QuVa Pharma, 1075 West Park One Drive, Suite 100, Sugar Land, Tx 77478. NDC: 70092-1259-75; Lot, expiry: Lot 10140303, exp 04/14/2025; Lots 10140867, 10140868, exp 04/24/2025; Lot 10140965, exp 04/28/20251,765 cassettes
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Now

    Immediately stop using the recalled fentanyl injections if you have them.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 27 days after the firm started it.

1. Firm started the recall: Mar 6, 202512. FDA classified it Class II: Mar 25, 202523. Published in FDA’s Enforcement Report: Apr 2, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What is the specific product being recalled?

The recalled product is fentanyl citrate injection (200 mcg/100 mL) with 0.125% bupivacaine, compounded for epidural use.

Similar recalls

Other QuVa Pharma recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0296-2025 (March 6, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0296-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA